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Abstract
Background and purpose: The effects of the coronavirus disease 2019 (COVID- 19) pan-
demic on telemedical care have not been described on a national level. Thus, we investi-
gated the medical stroke treatment situation before, during, and after the first lockdown 
in Germany.
Methods: In this nationwide, multicenter study, data from 14 telemedical networks in-
cluding 31 network centers and 155 spoke hospitals covering large parts of Germany 
were analyzed regarding patients' characteristics, stroke type/severity, and acute stroke 
treatment. A survey focusing on potential shortcomings of in- hospital and (telemedical) 
stroke care during the pandemic was conducted.
Results: Between January 2018 and June 2020, 67,033 telemedical consultations and 
38,895 telemedical stroke consultations were conducted. A significant decline of tele-
medical (p < 0.001) and telemedical stroke consultations (p < 0.001) during the lockdown 
in March/April 2020 and a reciprocal increase after relaxation of COVID- 19 measures in 
May/June 2020 were observed. Compared to 2018– 2019, neither stroke patients' age 
(p = 0.38), gender (p = 0.44), nor severity of ischemic stroke (p = 0.32) differed in March/
April 2020. Whereas the proportion of ischemic stroke patients for whom endovascular 
treatment (14.3% vs. 14.6%; p = 0.85) was recommended remained stable, there was 
a nonsignificant trend toward a lower proportion of recommendation of intravenous 
thrombolysis during the lockdown (19.0% vs. 22.1%; p = 0.052). Despite the majority of 
participating network centers treating patients with COVID- 19, there were no relevant 
shortcomings reported regarding in- hospital stroke treatment or telemedical stroke care.
Conclusions: Telemedical stroke care in Germany was able to provide full service despite 
the COVID- 19 pandemic, but telemedical consultations declined abruptly during the lock-
down period and normalized after relaxation of COVID- 19 measures in Germany.
K E Y W O R D S
COVID- 19, SARS- CoV- 2, stroke, survey, telemedicine
INTRODUC TION
The World Health Organization (WHO) declared global pandemic 
of coronavirus disease 2019 (COVID- 19) due to the severe acute 
respiratory syndrome coronavirus 2 (SARS- CoV- 2) has affected 
more than 108 million people worldwide, had caused more than 
2.3 million deaths up to 16 February 2020, and is currently un-
dergoing a second wave of infections in various countries [1]. The 
COVID- 19 pandemic has unforeseen implications for all areas of 
medicine, including the care of patients with cerebrovascular dis-
eases, as neurological departments have redistributed their ca-
pacity to ensure the care of patients with COVID- 19. Furthermore, 
a decreased number of hospitalized stroke patients has repeatedly 
been reported, obviously due to social distancing and isolation or 
due to concerns regarding an increased in- hospital risk of SARS- 
CoV- 2 infection [2– 7].
On the other hand, there is growing evidence that COVID- 19 
is linked to acquired hypercoagulability, with an increased risk 
of venous as well as arterial thrombosis and embolism [8– 10]. In 
addition, COVID- 19- related depletion of angiotensin- converting 
enzyme 2 and subsequent endothelial dysfunction may also in-
crease the risk of stroke [11]. In hospitalized COVID- 19 patients, an 
ischemic stroke rate up to 3% and a hemorrhagic stroke rate up to 
0.5% were reported [12– 14]. Furthermore, COVID- 19- associated 
ischemic strokes are reported to be more severe, with worse func-
tional outcome and higher mortality than non- COVID- 19 ischemic 
strokes [15].
Telemedicine is widely used to facilitate care of stroke patients 
in regional network hospitals (without a 24/7 presence of a neu-
rologist) by stroke specialists at dedicated network centers. It has 
been demonstrated that this hub and spoke model improves the 
quality of stroke care in spoke hospitals, reducing mortality and 
morbidity of stroke patients [16]. In Germany, 22 telemedical stroke 
networks provide a substantial part of acute stroke care in rural 
areas. During the COVID- 19 pandemic, it has been recommended 
to strengthen telemedical stroke networks, because teleneurology 
can play an important role in protecting patients and physicians 
from potential exposure to COVID- 19 in outpatient and inpatient 
care (i.e., by optimizing the allocation of treatment resources and 
minimizing transport of patients between hospitals) [17].
    | 3269COVID-­19­AND­TELECONSULTATIONS­IN­GERMANY
Single- center observations from the United States and Germany 
report a significant decline in teleconsultations during the peak 
phase of the COVID- 19 pandemic in March and April 2020 [18– 21]. 
However, the implications of the COVID- 19 pandemic for telemed-
ical stroke care have not been analyzed in detail on a national level. 
On behalf of the German telemedical stroke networks, we analyzed 
routine data of telemedical consultations in German telemedical 
networks, hypothesizing a decline of stroke teleconsultations during 
the COVID- 19 pandemic. Furthermore, we compared data of fed-
eral states in the southern and nonsouthern part of Germany, as the 
COVID- 19 incidence in southern Germany was higher in the first half 
of 2020. Using a survey, we assessed potential shortcomings of in- 
hospital and (telemedical) stroke care in Germany in the first half of 
2020.
MATERIAL S AND METHODS
In this nationwide, multicenter study, all coordinators of German 
telemedical stroke networks, cooperating within the working 
group "Telemedical Stroke Care" of the German Stroke Society, 
were asked to contribute their data and to return a standardized 
questionnaire. Data of individual telemedical networks were in-
cluded if teleconsultations had been documented 24/7 since 
January 2018. In accordance with local rules of data protection, 
anonymized data on teleconsultations were sent to the Institute 
of Clinical Epidemiology and Biometry, University Würzburg, 
Germany. In addition to the date of teleconsultation, patients' age, 
gender, stroke type (ischemic stroke, transient ischemic attack, 
hemorrhagic stroke, subarachnoid hemorrhage), stroke sever-
ity at time of consultation using the National Institutes of Health 
Stroke Scale (NIHSS) [22], and whether intravenous thrombolysis 
and/or endovascular treatment was recommended were assessed. 
Furthermore, the local network coordinators were asked to return 
a survey focusing on potential shortcomings of in- hospital stroke 
care as well as telemedical stroke care during the COVID- 19 pan-
demic (Appendix S1), which was cross- referenced with spoke hos-
pitals and network center(s).
The incidence of SARS- CoV- 2 infections in all federal states of 
Germany was reported on a weekly basis by the German govern-
ment's central Public Health Institute (the Robert Koch Institute, 
Berlin, Germany; https://www.rki.de). As Bavaria and Baden- 
Württemberg (both in the south of Germany) represented the only 
two federal states with a mean weekly incidence of more than 40 
SARS- CoV- 2 infections per 100,000 people, we compared tele-
consultations of the participating networks in these two southern 
federal states of Germany to teleconsultations in the participating 
networks in other (“nonsouthern”) parts of Germany (Figure 1, Table 
S1). Two telemedical stroke networks (FAST, Stroke- ARTEV) were 
allocated according to the localization of spoke hospitals requesting 
teleconsultations.
On 9 January 2020, the WHO declared the first COVID- 
19- related death worldwide, and on 27 January 2020, the first 
SARS- CoV- 2 infection in Germany was detected. The first death due 
to COVID- 19 in Germany was reported on 9 March 2020. On 16 
March 2020, nationwide restriction measures (closing of schools, 
childcare facilities, and many stores) became effective in Germany. 
Thus, we defined this date as the start of the COVID- 19 pandemic- 
related lockdown. In March 2020, we intended to analyze telecon-
sultations within the period from 1 January 2018 and 30 April 2020. 
As on 20 April 2020, relaxation of COVID- 19 measures was imple-
mented in Germany, we expanded data assessment to 30 June 2020, 
to be able to assess the impact of relaxation of COVID- 19 measures 
on telemedical care.
In March 2020, the following research questions were defined. (i) 
Are we experiencing a temporary decline in the number of telecon-
sultations among (stroke) patients during the COVID- 19 pandemic 
in Germany? (ii) Do patient characteristics, stroke type/severity, or 
acute stroke treatment differ during the peak phase of the COVID- 19 
pandemic? (iii) Do changes of telemedical stroke care differ in fed-
eral states with comparably high incidence of COVID- 19? (iv) Are 
there shortcomings of in- hospital stroke care or telemedical stroke 
care during the COVID- 19 pandemic?
Statistical analysis
Statistical analysis was performed using the Statistical Package 
for the Social Sciences version 26.0 (IBM SPSS Statistics), except 
for time series decompositions using R 4.0.2, the prophet (v0.6.1; 
Taylor & Letham 2020) package. Associations between patients' 
characteristics and time period were evaluated using Kruskal– 
Wallis test with post hoc tests for differences in continuous vari-
ables and chi- squared test for categorical variables. All reported 
p- values are two- sided, and the significance level was set to 0.05. 
Adjustment for multiple comparisons was applied in post hoc 
analyses. The impact of COVID- 19 measures on the main outcome 
defined as daily number of consultations was evaluated by inter-
rupted time series analysis using segmented Poisson regression 
(Appendix S1).
Standard protocol approvals, registrations, and 
patient consents
This study was approved with a waiver of authorization by the 
data security officer at the University and University Hospital 
of Würzburg, Germany and was in accordance with the 1964 
Declaration of Helsinki and its later amendments.
RESULTS
Data of 14 telemedical networks were included in the analysis, 
including 31 network centers (range = 1– 6 centers per network; 
Figure S1) and 155 spoke hospitals (range = 3– 24 per telemedical 
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stroke network) in nine federal states of Germany (Table S1). Ten of 
14 telemedical networks provided additional data on teleconsulta-
tions from 1 May 2020 to 30 June 2020.
Teleconsultations during the observation period
Overall, 67,033 teleconsultations were completed within the obser-
vation period in participating networks (Table 1). Mean age of pa-
tients was 71 (SD = ±16) years, and 31,658 (49.6%) patients were 
female. Interrupted time series analysis revealed a constant level 
of telemedical consultations without a significant trend between 1 
January 2020 and 15 March 2020 (β1 = 1.0, p = 0.829; Table S2). 
The mean daily rate of telemedical consultations dropped by 13% in 
the first week of the lockdown (β4 = 0.87, p = 0.015) and by an ad-
ditional 16% between 23 March 2020 and 19 April 2020 (β2 = 0.71, 
p < 0.001). After the relaxation of COVID- 19 restrictions, the mean 
daily rate of telemedical consultations increased, but was lower 
(−6%, p = 0.494) compared to the mean daily rate of telemedical 
stroke consultations in the time period before the lockdown (be-
tween 1 January 2020 and 15 March 2020). As depicted in Figure 1, 
the number of telemedical consultations was inversely correlated to 
the incidence of SARS- CoV- 2 infections in the federal states of par-
ticipating networks.
The mean daily rate of telemedical consultations in Bavaria and 
Baden- Württemberg dropped by 11% in the first week of the lock-
down (β4 = 0.89, p = 0.066), and by an additional 16% between 23 
March 2020 and 19 April 2020 (β2 = 0.73, p < 0.001; Table 2, Figure 
S2A). The mean daily rate of telemedical consultations in the non-
southern networks dropped by 21% in the first week of the lock-
down (β4 = 0.79, p = 0.077), and by an additional 15% between 23 
March 2020 and 19 April 2020 (β2 = 0.64, p < 0.001; Table 2, Figure 
S2B). After the relaxation of COVID- 19 restrictions, the mean daily 
rate of telemedical consultations increased, but was lower (−6%, 
p = 0.49) in the two southern federate states and in the nonsouthern 
federal states (−5%, p = 0.77), if compared to the mean daily rate of 
telemedical stroke consultations in the time period before the lock-
down (between 1 January 2020 and 15 March 2020).
Teleconsultations in stroke patients during the 
observation period
Of 55,958 teleconsultations with available diagnosis, 38,895 (69.5%) 
teleconsultations were stroke related (Table 2). The mean age of 
stroke patients was 73 (SD = ±14) years, and 18,674 (48.7%) were 
female. Interrupted time series analysis revealed a constant level of 
telemedical stroke consultations without a significant trend between 
F I G U R E  1  All (stroke and nonstroke) telemedical consultations (red line, red numbers) per 2 weeks from January 2018 to June 2020 in 10 
German telemedical stroke networks. The number of severe acute respiratory syndrome coronavirus 2 (SARS- CoV- 2) infections (gray) per 2 
weeks in nine German federal states of participating telemedical stroke networks (according to the Robert Koch Institute, Berlin, Germany) 
is shown. *First death due to coronavirus disease 2019 (COVID- 19) worldwide on 9 January 2020. **First patient with COVID- 19 in Germany 
on 27 January 2020. ***First COVID- 19- related death in Germany on 9 March 2020. ****Announcement of restriction measures in Germany 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1 January 2020 and 15 March 2020 (β1 = 1.0, p = 0.414). Compared 
to this period, the mean daily rate of telemedical stroke consulta-
tions dropped by 12% in the first week of the lockdown (β4 = 0.88, 
p = 0.094), and by an additional 24% between 23 March 2020 and 
19 April 2020 (β2 = 0.76, p < 0.001; Figure S3). After the relaxation 
of COVID- 19 restrictions, the mean daily rate of telemedical stroke 
consultations increased, but was lower (−3%, p = 0.774), if compared 
to the mean daily rate of telemedical stroke consultations in the time 
period before the lockdown (between 1 January 2020 and 15 March 
2020).
Information on stroke type was available in 33,191 patients, in-
cluding 24,168 (72.8%) patients with ischemic stroke, 7,022 (21.2%) 
with transient ischemic attack (TIA), 1,377 (4.1%) with hemorrhagic 
stroke, 338 (1.0%) with subarachnoid hemorrhage, and 286 (0.9%) 
with subdural or epidural hemorrhage. The NIHSS score at the time 
of consultation was available in 19,974 patients with ischemic stroke. 
Overall, 11,724 (58.7%) patients had an NIHSS score of 0– 3 points, 
5,469 (27.3%) had an NIHSS score of 4– 10 points, and 2,781 (13.9%) 
had an NIHSS score greater than 10 points.
As depicted in Figure 2, stroke consultations during the lockdown 
period did not differ regarding patients' age (p = 0.32; Figure 2a), 
gender (p = 0.44; Figure 2b), or stroke severity (p = 0.32; Figure 2c). 
Within the observation period before 15 March 2020, intravenous 
thrombolysis was recommended in 4,520 (19.8%) and endovascular 
treatment in 2,802 (12.3%) patients with ischemic stroke (Figure 3). 
During the lockdown period, the mean daily rate of recommenda-
tions to perform intravenous thrombolysis significantly declined 
(4.0 vs. 5.9 before the lockdown period, p < 0.001), and there was 
a nonsignificant trend toward a lower rate of recommending intra-
venous thrombolysis in ischemic stroke patients (19.0% vs. 22.1% 
before the lockdown period, p = 0.052). The mean daily rate of rec-
ommendations to perform endovascular treatment declined signifi-
cantly during the lockdown period (3.0 vs. 3.9 before the lockdown 
period, p = 0.02), whereas the rate of recommendations to perform 
endovascular treatment in ischemic stroke patients remained stable 
(14.3% vs. 14.6% before the lockdown period, p = 0.85).
Survey among coordinators of participating 
telemedical stroke networks
The survey (Appendix S1) was completed by coordinators of 14 
telemedical stroke networks. Telemedical stroke care was limited 
at one (3%) of 31 network centers, which was reported to be un-
related to the COVID- 19 pandemic. In- hospital stroke care was 
limited in at least one spoke hospital in six (43%) of 14 telemedical 
stroke networks during the COVID- 19 pandemic, because the ca-
pacity of monitoring beds was insufficient (n = 4) or no stroke care 
could be provided at the spoke hospital temporarily (n = 4). Patients 
with COVID- 19 were treated at 30 (97%) of 31 network centers. In 
five (16%) network centers, treatment of nonstroke patients with 
COVID- 19 affected stroke care, as monitoring beds (on the intensive 
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COVID- 19 (n = 3), diagnostic procedures in stroke patients were de-
layed or limited (n = 1), or there were COVID- 19- related shortages 
of staff (n = 1). Seventeen (55%) network centers reported treat-
ment of stroke patients with COVID- 19, and eight (26%) network 
centers reported treatment of these patients at the Department of 
Neurology. In- hospital treatment of stroke patients with COVID- 19 
affected the care of stroke patients without COVID- 19 in one (3%) 
telemedical network, as monitoring beds were closed, and diagnos-
tic procedures were delayed or canceled due to COVID- 19- related 
hygiene regulations.
DISCUSSION
In this representative nationwide study, we demonstrate a sig-
nificant decline of telemedical consultations as well as telemedi-
cal stroke consultations during the COVID- 19 pandemic- related 
lockdown in Germany. Based on interrupted time series analysis, 
we furthermore observed a rebound of teleconsultations after the 
relaxation of COVID- 19 restrictions in Germany. Interestingly, the 
rate of telemedical consultations was inversely correlated to the 
incidence of SARS- CoV- 2 in the federal states of participating net-
works (not representing all parts of Germany; Figure 1). However, 
the observed fluctuations of (stroke) teleconsultations were similarly 
observed in federal states with rather high or rather low incidence of 
SARS- CoV- 2 infections (Figure 4).
During the lockdown period, neither patients' age, gender, 
nor stroke type and stroke severity showed significant changes. 
This is not in line with previous publications, indicating a signif-
icant decline of the proportion of minor stroke and TIA patients 
[23]. Published single- center or single- network observations re-
ported increasing or decreasing proportions of patients undergo-
ing recanalization therapy, which was not the case in our analysis 
[18,19,24]. We observed a lower rate of recommendations to per-
form intravenous thrombolysis during the lockdown, but this was 
not statistically significant, as similarly reported in the German 
TEMPiS network (please see Table S1 for details) [20,21]. This 
finding may indicate that stroke patients may have arrived at later 
time points in the spoke hospitals.
Our results are also in line with the observed decline of in- 
hospital stroke treatment during March and April 2020 in several 
health care systems and also in Germany [25– 30]. As a nation-
wide survey among German neurologists running a certified stroke 
unit revealed that 93% reported a decrease of hospitalized stroke 
F I G U R E  2  (a) Telemedical stroke consultations per 2 weeks 
from January 2018 to April 2020 in 14 German telemedical stroke 
networks with regard to patients' age: <60 years (blue line), 60– 
80 years (green line), and >80 years (yellow line). (b) Telemedical 
consultations per 2 weeks from January 2018 to April 2020 in 14 
German telemedical stroke networks regarding male (blue line) 
and female sex (red line). (c) Telemedical stroke consultations per 2 
weeks from January 2018 to April 2020 in 14 German telemedical 
stroke networks. Transient ischemic attack patients (blue line), 
minor stroke patients (National Institutes of Health Stroke Scale 
[NIHSS] score = 0– 3 points, red line), patients with moderate stroke 
(NIHSS score = 4– 10 points, green line), and patients with severe 
stroke (NIHSS score > 10 points, orange line) are shown. [Colour 
figure can be viewed at wileyonlinelibrary.com]
    | 3275COVID-­19­AND­TELECONSULTATIONS­IN­GERMANY
patients at their institution [31], it seems plausible that the ob-
served alterations of telemedical stroke consultations mirror hospi-
talized stroke care during the COVID- 19- related lockdown period. 
According to our data, it is plausible that the observed fluctuations 
of telemedical consultations and telemedical stroke consultations in 
particular reflect an avoidance of in- hospital presentation during the 
COVID- 19- related lockdown period.
The conducted survey among coordinators of participating net-
work centers revealed that almost all hospitals treated patients with 
COVID- 19, and about 60% treated stroke patients with COVID- 19. 
In- hospital treatment of stroke patients and diagnostic procedures 
in stroke patients were considered to be normal at the vast majority 
of stroke centers. This is discrepant from a recent survey including 
426 stroke care providers from 55 countries, reporting shortcom-
ings in stroke care in 77% of European respondents [32]. A possible 
explanation for this discrepancy could be the higher rate of inten-
sive care facilities and a lower incidence of SARS- CoV- 2 infections 
in Germany compared to other European countries. About 40% of 
the telemedical stroke network coordinators reported limited stroke 
care in at least one spoke hospital during the lockdown period. Of 
note, no network was reported to have limited their telemedicine 
service. As the maintenance of stroke care is crucial to limit stroke- 
related mortality and disability, it is reassuring that there was neither 
a shortage of telemedical staff nor restrictions by technical problems 
during the COVID- 19 pandemic in the first half of 2020 in Germany.
Despite the reported strengths, the following limitations have 
to be taken into account. First, two German telemedical stroke net-
works were not able to add data to our analysis, as data assessment 
starting in January 2018 was mandatory to enable time series anal-
yses. Nevertheless, the participating telemedical networks cover the 
F I G U R E  3  Telemedical stroke 
consultations per 2 weeks from 
January 2018 to April 2020 in 14 
German telemedical stroke networks. 
Recommendations for intravenous 
thrombolysis (blue line) or mechanical 
recanalization (red line) are shown. [Colour 
figure can be viewed at wileyonlinelibrary.
com]
F I G U R E  4  Telemedical stroke 
consultations per 2 weeks from January 
2018 to April 2020 in 14 German 
telemedical stroke networks (red line), 
in seven telemedical stroke networks in 
the south of Germany (blue line), and in 
seven telemedical stroke networks in the 
nonsouthern parts of Germany (orange 
line) [Colour figure can be viewed at 
wileyonlinelibrary.com]
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vast majority of teleconsultations in Germany. Second, the local inci-
dence of stroke was not available, as our analysis is based on telecon-
sultation data only. Furthermore, we are unable to assess whether 
the proportion of patients taken directly to the specialist hospitals 
differed by time. However, it is unlikely that the source population 
of the treating hospitals changed during the pandemic period, and a 
similar decline of in- hospital stroke patients was reported in Germany 
[30]. Third, the reasons for the observed alterations in telemedical 
consultations cannot be elucidated in more detail and, therefore, 
should be addressed in future studies. Fourth, two of 14 networks 
were unable to provide data on stroke type, and three networks were 
unable to provide the NIHSS score on admission. However, given the 
large number of hospitals and patients involved and a constant pro-
portion of available information on stroke type and stroke severity, 
a substantial bias is unlikely. Fifth, four of 14 telemedical networks 
did not provide data from May/June 2020, which might have had an 
impact on the results of the postlockdown period. However, data of 
all remaining telemedical networks showed a reciprocal increase of 
telemedical consultations after relaxation of COVID- 19 measures, 
leading us to the assumption that a substantial bias is unlikely. Sixth, 
data of the TEMPiS network were already published [20,21].
Summary
Telemedical consultations and telemedical stroke consultations 
significantly declined during the COVID- 19 pandemic- related 
lockdown in Germany and began to normalize after relaxation of 
COVID- 19 measures. Decline of telemedical (stroke) consultations 
was observed nationwide in telemedical networks, independent of 
the incidence of SARS- CoV- 2 infections in the southern and non-
southern parts of Germany. We observed a lower rate of systemic 
thrombolysis during the lockdown period in March/April 2020, but 
this was not statistically significant. Although the majority of the 
participating network centers treated COVID- 19 patients, relevant 
shortcomings regarding in- hospital treatment as well as telemedi-
cal stroke care were not reported. Our representative nationwide 
study demonstrates the robustness of teleconsultation services in 
Germany during the COVID- 19 pandemic in the first half of 2020.
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